10x Genomics (TXG)

Last Closing Price: 57.07 (2026-11-18)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

10x Genomics (TXG) had Cost of Goods Sold of $37.74M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$150.67M
$-19.43M
Cost of Goods Sold
$37.74M
$112.93M
$166.72M
$-16.06M
$-2.42M
$-18.48M
$-18.48M
$-19.43M
$-19.43M
$-19.43M
$-19.43M
$-16.06M
$-4.45M
130.81M
130.81M
$-0.15
$-0.15
Balance Sheet Financials
$718.63M
$210.24M
$344.50M
$1.06B
$140.37M
--
$84.72M
$225.09M
$838.04M
$772.46M
$838.04M
131.53M
Cash Flow Statement Financials
$58.93M
$-9.55M
$3.12M
$473.97M
$526.19M
$52.22M
$71.35M
--
--
Fundamental Metrics & Ratios
5.12
--
--
--
--
74.95%
-10.66%
-10.66%
--
-12.26%
-12.89%
$54.77M
--
--
--
0.14
0.58
2.56
35.10
-2.32%
-2.51%
-1.83%
-2.32%
$6.37
$0.42
$0.45